Loading stock data…
Kewaunee Scientific Corporation designs (KEQU)
$36.01-0.33 (-0.91%)
Market ClosedLast close Jul 24
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Kewaunee Scientific Corporation in the Consumer Cyclical sector is trading at $36.01 with a market capitalization of $107M. The stock is currently near its 52-week low of $33.27, remaining 6.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $71.40M↑ | $69.40M↓ | $70.10M↓ | $71.10M↓ | $77.15M |
| Gross Profit | $21.25M↑ | $18.55M↓ | $19.72M↓ | $20.93M↓ | $24.04M |
| Operating Income | $5.22M↑ | $2.58M↓ | $4.11M↓ | $4.81M↓ | $8.50M |
| Net Income | $3.39M↑ | $692,000↓ | $2.44M↓ | $3.09M↓ | $4.85M |
Peer Comparison
AMZNTSLAHD
Fundamentals
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and woo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$106.91M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.68%
Volume
Today's trading volume
860
Recent News
The Zacks Analyst Blog Highlights Eli Lilly, Costco Wholesale, Morgan Stanley and Kewaunee Scientific
Eli Lilly's expanding GLP-1 portfolio and pipeline remain in focus as demand stays strong ahead of its second-quarter earnings results.
Top Research Reports for Eli Lilly, Costco & Morgan Stanley
Eli Lilly's GLP-1 portfolio, pipeline progress and 2026 acquisitions are driving growth despite pricing pressure and rising competition.
Kewaunee Scientific Q4 Earnings & Sales Fall Y/Y on Project Timing
KEQU posts lower Q4 sales and EPS as project timing and Middle East shipment delays weigh on the results despite annual revenue growth.
The Zacks Analyst Blog Highlights Caterpillar, Texas Instruments, Boeing, Kewaunee Scientific and Vaso
Caterpillar, Texas Instruments and Boeing stand out in Zacks research as strong demand, backlog and data center growth drive performance outlooks.
Top Stock Reports for Caterpillar, Texas Instruments & Boeing
Today's Research Daily features new research reports on 16 major stocks, including Caterpillar Inc. (CAT), Texas Instruments Inc. (TXN) and The Boeing Company (BA), as well as two micro-cap stocks Kewaunee Scientific Corp. (KEQU) and Vaso Corp. (VASO).